Using patient reports to adjust treatment for autoimmune diseases
Part of Bones, joints & muscles, Eyes & vision, Genetic & congenital, Hormones & metabolism, Immune system & allergy, Mouth & dental, Skin clinical trials.
This study looks at whether doctors consider patient “electronic reports” (completed online/phone) when deciding how often to change treatment. It may help improve how well treatment plans match how patients feel over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old
- Have one of these diagnosed conditions: rheumatoid arthritis, gout, lupus, or Sjögren’s syndrome
- Agree to participate (by consent or non-opposition, depending on country)
- Have reliable internet access plus email and a mobile phone, and be able to use them
- Be able and willing to follow the study for about 2 years and complete the reports
- Not have certain major limits, like a memory/brain disease that affects thinking or an expected life span under 1 year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study collects samples and information from people with rheumatoid arthritis, lupus, or scleroderma, plus healthy volunteers, to better understand how the immune system works in these conditions. By comparing these groups, researchers hope to find new ways to treat and manage autoimmune diseases.
This study looks at how well people with rheumatoid arthritis (RA) take their RA medicines—especially medicines like methotrexate and other targeted or biologic treatments. It may help improve medication adherence (taking doses correctly) and supports safer, more consistent treatment at home.
This study is testing an experimental medicine called PF-08154225 to see if it can help treat several autoimmune conditions, including rheumatoid arthritis, lupus, and related disorders. It might reduce disease activity or symptoms in people who have not found relief from other treatments.
This trial tests a new drug called GSK5926371 for people with certain autoimmune diseases that affect the joints, skin, and other tissues. It aims to see if the drug is safe and how well it works.
This study looks at how people with rheumatic diseases (like arthritis or lupus) experience pain, by collecting information through questionnaires and simple tests. The goal is to better understand different types of pain to improve treatments.
This study tests if a digital app called RheumaBuddy4.1 can help manage rheumatoid arthritis symptoms. You would use the app at home and report how you feel.
Hear when a new Gout trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.